Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Chen, Chien Chang ^a   Hsu, Yu Jung ^b   Lee, Tsung Ming ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Endothelin 1; Myocardial infarction; Superoxide; Ventricular remodeling

Indexed keywords

ALLOPURINOL; ATRASENTAN; BENZBROMARONE; ENDOTHELIN 1; HYDROETHIDINE; ISOPROSTANE; MESSENGER RNA; OTERACIL; SUPEROXIDE DISMUTASE; TEMPOL; URIC ACID; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERURICEMIA; LIGATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WESTERN BLOTTING;

ALLOPURINOL; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; FIBROSIS; GOUT SUPPRESSANTS; HYPERTROPHY, LEFT VENTRICULAR; HYPERURICEMIA; ISOPROSTANES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATIVE STRESS; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RNA, MESSENGER; SPIN LABELS; SUPEROXIDES; TIME FACTORS; UP-REGULATION; URIC ACID; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; XANTHINE OXIDASE;

EID: 80052329369     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01071.2010     Document Type: Article

References (52)

1. Bax JJ, Schinkel AF, Boersma E, Elhendy A, Rizzello V, Maat A, Roelandt JR, van der Wall EE, Poldermans D. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 110: II18-II22, 2004.
2. Becker BF, Reinholz N, Ozçelik T, Leipert B, Gerlach E. Uric acid as radical scavenger and antioxidant in the heart. Pflügers Arch 415: 127-135, 1989.
3. Bélichard P, Savard P, Cardinal R, Nadeau R, Gosselin H, Paradis P, Rouleau JL. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol 23: 505-513, 1994.
4. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001.
5. Cheng TH, Lin JW, Chao HH, Chen YL, Chen CH, Chan P, Liu JC. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int J Cardiol 139: 42-49, 2010.
6. de Jong JW, van der Meer P, Nieukoop AS, Huizer T, Stroeve RJ, Bos E. Xanthine oxidoreductase activity in perfused hearts of various species, including humans. Circ Res 67: 770-773, 1990.
7. Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction. A new action for an old drug? Circulation 110: 2175-2179, 2004.
8. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114: 2508-2516, 2006.
9. Gourine AV, Hu Q, Sander PR, Kuzmin AI, Hanafy N, Davydova SA, Zaretsky DV, Zhang J. Interstitial purine metabolites in hearts with LV remodeling. Am J Physiol Heart Circ Physiol 286: H677-H684, 2004.
10. Hare JM, Mangal B, Brown J, Fisher C Jr, Freudenberger R, Colucci WS, Mann DL, Liu P, Givertz MM, Schwarz RP; OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 51: 2301-2309, 2008.
11. Huang CC, Tsai SC, Lin WT. Potential ergogenic effects of L-arginine against oxidative and inflammatory stress induced by acute exercise in aging rats. Exp Gerontol 43: 571-577, 2008.
12. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 25: 425-433, 2005.
13. Kaufmann P, Török M, Hänni A, Roberts P, Gasser R, Krähenbühl S. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology 41: 925-935, 2005.
14. Kawana M, Lee ME, Quertermous EE, Quertermous T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 15: 4225-4231, 1995.
15. Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S, Utsumi H, Takeshita A. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87: 392-398, 2000.
16. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, Tei C, Hiraoka H, Sonoda M, Tsuchihashi K, Shimoyama N, Honda T, Ogata Y, Matsui K, Ogawa H. Japanese Acute Coronary Syndrome Study (JACSS) Investigators Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 96: 489-495, 2005.
17. Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 120: 1939-1949, 2010.
18. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 54: 2688-2696, 2006.
19. Lee TM, Chen CC, Lin MS, Chang NC. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats. Am J Physiol Heart Circ Physiol 294: H1871-H1879, 2008.
20. Lee TM, Lai PY, Chang NC. Effect of N-acetylcysteine on sympathetic reinnervation in post-infarcted rat hearts. Cardiovasc Res 85: 137-146, 2010.
21. Lee TM, Lin MS, Chang NC. Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts. J Am Coll Cardiol 51: 1309-1318, 2008.
22. Lee TM, Lin MS, Chou TF, Tsai CH, Chang NC. Adjunctive 17-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein. Cardiovasc Res 63: 109-117, 2004.
23. Lee TM, Lin MS, Tsai CH, Chang NC. Beneficial effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats. Am J Physiol Heart Circ Physiol 291: H2705-H2713, 2006.
24. Lijnen P, Papparella I, Petrov V, Semplicini A, Fagard R. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J Hypertens 24: 757-766, 2006.
25. Meisinger C, Koenig W, Baumert J, Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 28: 1186-1192, 2008.
26. Miyauchi T, Masaki T. Pathophysiology of endothelin in cardiovascular system. Annu Rev Physiol 61: 391-415, 1999.
27. Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 25: 279-286, 2005.
28. Murugaiyah V, Chan KL. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents. J Ethnopharmacol 124: 233-239, 2009.
29. Naumova AV, Chacko VP, Ouwerkerk R, Stull L, Marbán E, Weiss RG. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. Am J Physiol Heart Circ Physiol 290: H837-H843, 2006.
30. Patschan D, Patschan S, Gobe GG, Chintala S, Goligorsky MS. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am Soc Nephrol 18: 1516-1524, 2007.
31. Radi R, Tan S, Prodanov E, Evans RA, Parks DA. Inhibition of xanthine oxidase by uric acid and its influence on superoxide radical production. Biochim Biophys Acta 1122: 178-182, 1992.
32. Rodilla F, Sanchez-Beltran MJ, Izquierdo R, Gomez-Ruiz MD, Cabo J. Inhibition of purine catabolism by benzbromarone in isolated rat liver cells. Comparison with allopurinol and probenecid. Biochem Pharmacol 37: 3561-3563, 1988.
33. Sánchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, Franco M, Rodríguez-Iturbe B, Johnson RJ. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 295: F1134-F1141, 2008.
34. Sánchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaría J, Nakagawa T, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105-F1110, 2002.
35. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293: C584-C596, 2007.
36. Schuh A, Liehn EA, Sasse A, Schneider R, Neuss S, Weber C, Kelm M, Merx MW. Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res Cardiol 104: 403-411, 2009.
37. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521, 2003.
38. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376: 333-337, 2000.
39. Stull LB, Leppo MK, Szweda L, Gao WD, Marbán E. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy. Circ Res 95: 1005-1011, 2004.
40. Sun Y. Oxidative stress and cardiac repair/remodeling following infarction. Am J Med Sci 334: 197-205, 2007.
41. Tan S, Radi R, Gaudier F, Evans RA, Rivera A, Kirk KA, Parks DA. Physiologic levels of uric acid inhibit xanthine oxidase in human plasma. Pediatr Res 34: 303-307, 1993.
42. Terada LS, Rubinstein JD, Lesnefsky EJ, Horwitz LD, Leff JA, Repine JE. Existence and participation of xanthine oxidase in reperfusion injury of ischemic rabbit myocardium. Am J Physiol Heart Circ Physiol 260: H805-H810, 1991.
43. Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, Cruickshank JM, Devereux RB, Giles TD, Korsgaard N, Leier CV. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 20: 3-16, 1992.
44. Westerfeld WW, Richert DA, Higgins ES. Further studies with xanthine oxidase inhibitors. J Biol Chem 234, 1897-1900, 1959.
45. Xia QG, Chung O, Spitznagel H, Illner S, Jänichen G, Rossius B, Gohlke P, Unger T. Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure. Cardiovasc Res 49: 110-117, 2001.
46. Xia Z, Godin DV, Ansley DM. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 59: 113-121, 2003.
47. Xiao J, She Q, Wang Y, Luo K, Yin Y, Hu R, Huang K. Effect of allopurinol on cardiomyocyte apoptosis in rats after myocardial infarction. Eur J Heart Fail 11: 20-27, 2009.
48. Yeldandi AV, Yeldandi V, Kumar S, Murthy CV, Wang XD, Alvares K, Rao MS, Reddy JK. Molecular evolution of the urate oxidaseencoding gene in hominoid primates: nonsense mutations. Gene 109: 281-284, 1991.
49. Yu MA, Sánchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28: 1234-1242, 2010.
50. Yu X, Patterson E, Huang S, Garrett MW, Kem DC. Tumor necrosis factor a, rapid ventricular tachyarrhythmia, and infarct size in canine models of myocardial infarction. J Cardiovasc Pharmacol 45: 153-159, 2005.
51. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH. Extracellular signalregulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylphrine-induced cardiomyocyte hypertrophy. J Biol Chem 275: 37895-37901, 2000.
52. Zhang M, Shah AM. Role of reactive oxygen species in myocardial remodeling. Curr Heart Fail Rep 4: 26-30, 2007.